NTRA - Natera: Overdue For A Breather

2024-06-03 11:04:50 ET

Summary

• Today, we look at Natera, Inc., a diagnostic and molecular testing services company that has seen its stock rise over 150% since late October.
• The company achieved cash flow break even status in the first quarter ahead of schedule as Natura delivered outstanding Q1 results.
• The question is whether the stock can continue to rally now being valued at over nine times forward sales or if the equity is overdue for a breather.
• An analysis around Natera follows in the paragraphs below.

Today, we are putting diagnostic and molecular testing services concern Natera, Inc. ( NTRA ) in the spotlight. The stock is one of the best performing equities in the market in recent quarters and is up more than 150% since the end of the overall market swoon in late October of 2023. Can the good times continue for shareholders, or are the shares overdue for at least a breather? An analysis follows below....

For further details see: